Search for other papers by Ashley K Clift in
Google Scholar
PubMed
Department of Surgery, Warsaw Medical University, Warsaw, Poland
Search for other papers by Oskar Kornasiewicz in
Google Scholar
PubMed
Search for other papers by Panagiotis Drymousis in
Google Scholar
PubMed
Search for other papers by Omar Faiz in
Google Scholar
PubMed
Search for other papers by Harpreet S Wasan in
Google Scholar
PubMed
Search for other papers by James M Kinross in
Google Scholar
PubMed
Search for other papers by Thomas Cecil in
Google Scholar
PubMed
Search for other papers by Andrea Frilling in
Google Scholar
PubMed
Right hemicolectomy 32 DOD 20 50 Appendectomy 3 A, NED 21 55 Right hemicolectomy 4 A, NED *Recurrence at 18 months, but disease free at last follow-up. A, alive; DOD, died of disease; DR
Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Search for other papers by Yujie Ren in
Google Scholar
PubMed
Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Search for other papers by Xue Han in
Google Scholar
PubMed
Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Search for other papers by Yujiang Li in
Google Scholar
PubMed
Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Key Laboratory of TCM Syndrome and Treatment of Yingbing (Thyroid Disease) of State Administration of Traditional Chinese Medicine, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Search for other papers by Guofang Chen in
Google Scholar
PubMed
Search for other papers by Lin Jiang in
Google Scholar
PubMed
Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Key Laboratory of TCM Syndrome and Treatment of Yingbing (Thyroid Disease) of State Administration of Traditional Chinese Medicine, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Search for other papers by Chao Liu in
Google Scholar
PubMed
Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Search for other papers by Shuhang Xu in
Google Scholar
PubMed
, which was calculated as follows: IAR (%) = Va/preoperative tumor volume × 100%. The primary outcomes included local tumor progression, recurrence-free survival (RFS), and delayed surgery. Local tumor progression was defined as any of the following ( 23
Search for other papers by Ayana Suzuki in
Google Scholar
PubMed
Search for other papers by Mitsuyoshi Hirokawa in
Google Scholar
PubMed
Search for other papers by Izumi Otsuka in
Google Scholar
PubMed
Search for other papers by Akihiro Miya in
Google Scholar
PubMed
Search for other papers by Akira Miyauchi in
Google Scholar
PubMed
Search for other papers by Takashi Akamizu in
Google Scholar
PubMed
) Postoperative outcomes Follow-up period mean (range) (years) 11.2 (2.7–13.7) 11.5 (2.3–13.8) 12.4 (2.4–13.8) NS NS Progression free survival rate (10 years) 90.9% 79.6% 95.8% NS NS Recurrence 9.1% (3) 19
Search for other papers by Samira M Sadowski in
Google Scholar
PubMed
Search for other papers by Emanuel Christ in
Google Scholar
PubMed
Search for other papers by Benoit Bédat in
Google Scholar
PubMed
Search for other papers by Attila Kollár in
Google Scholar
PubMed
Search for other papers by Wolfram Karenovics in
Google Scholar
PubMed
Search for other papers by Aurel Perren in
Google Scholar
PubMed
Search for other papers by Frédéric Triponez in
Google Scholar
PubMed
Search for other papers by on behalf of the SwissNET registry in
Google Scholar
PubMed
following R0 resection, with no evidence of local recurrence or distant metastasis on imaging. Survival analyses using the Kaplan–Meier method were performed to determine outcomes, and log-rank test was performed for comparison. Statistical analyses were
Search for other papers by Alberto Giacinto Ambrogio in
Google Scholar
PubMed
Search for other papers by Massimiliano Andrioli in
Google Scholar
PubMed
Search for other papers by Martina De Martin in
Google Scholar
PubMed
Search for other papers by Francesco Cavagnini in
Google Scholar
PubMed
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
Search for other papers by Francesca Pecori Giraldi in
Google Scholar
PubMed
in others. This has given rise to the search for reliable markers of recurrence ( 1 , 7 ), usually at immediate postsurgical testing, but none has proven fully predictive for long-term, relapse-free survival. One potential recurrence prognostic is
Search for other papers by B C M Hermans in
Google Scholar
PubMed
Search for other papers by J L Derks in
Google Scholar
PubMed
Search for other papers by H J M Groen in
Google Scholar
PubMed
Search for other papers by J A Stigt in
Google Scholar
PubMed
Search for other papers by R J van Suylen in
Google Scholar
PubMed
Search for other papers by L M Hillen in
Google Scholar
PubMed
Search for other papers by E C van den Broek in
Google Scholar
PubMed
Search for other papers by E J M Speel in
Google Scholar
PubMed
Search for other papers by A-M C Dingemans in
Google Scholar
PubMed
; PFS, progression-free survival; PR, partial response; PY, packyears; RTx, radiotherapy; SRT, stereotactic radiotherapy; WBRT, whole brain radiotherapy. Mean Ki-67 PI was 59% (range 15–100%, Table 2 ). In 6/11 LCNEC Ki-67 PI was ≤40%. Both
Search for other papers by Ashley K Clift in
Google Scholar
PubMed
Search for other papers by Omar Faiz in
Google Scholar
PubMed
Search for other papers by Robert Goldin in
Google Scholar
PubMed
Search for other papers by John Martin in
Google Scholar
PubMed
Search for other papers by Harpreet Wasan in
Google Scholar
PubMed
Search for other papers by Marc-Olaf Liedke in
Google Scholar
PubMed
Search for other papers by Erik Schloericke in
Google Scholar
PubMed
Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland
Search for other papers by Anna Malczewska in
Google Scholar
PubMed
Search for other papers by Guido Rindi in
Google Scholar
PubMed
Search for other papers by Mark Kidd in
Google Scholar
PubMed
Search for other papers by Irvin M Modlin in
Google Scholar
PubMed
Search for other papers by Andrea Frilling in
Google Scholar
PubMed
. Nomograms predicting progression-free survival, overall survival, and pelvic recurrence in locally advanced cervical cancer developed from an analysis of identifiable prognostic factors in patients from nrg oncology/gynecologic oncology group randomized
Search for other papers by Logan Mills in
Google Scholar
PubMed
Search for other papers by Panagiotis Drymousis in
Google Scholar
PubMed
Search for other papers by Yogesh Vashist in
Google Scholar
PubMed
Search for other papers by Christoph Burdelski in
Google Scholar
PubMed
Search for other papers by Andreas Prachalias in
Google Scholar
PubMed
Search for other papers by Parthi Srinivasan in
Google Scholar
PubMed
Search for other papers by Krishna Menon in
Google Scholar
PubMed
Search for other papers by Corina Cotoi in
Google Scholar
PubMed
Search for other papers by Saboor Khan in
Google Scholar
PubMed
Search for other papers by Judith Cave in
Google Scholar
PubMed
Search for other papers by Thomas Armstrong in
Google Scholar
PubMed
Search for other papers by Martin O Weickert in
Google Scholar
PubMed
Search for other papers by Jakob Izbicki in
Google Scholar
PubMed
Search for other papers by Joerg Schrader in
Google Scholar
PubMed
Search for other papers by Andreja Frilling in
Google Scholar
PubMed
Search for other papers by John K Ramage in
Google Scholar
PubMed
Search for other papers by Raj Srirajaskanthan in
Google Scholar
PubMed
.005; *** P < 0.001. HR, hazard ratio; LNR, lymph node ratio; PFS, progression-free survival. Progression was defined by local recurrence, new or progressive metastases or death ( Table 4 ). The 11 cases of local recurrence were associated
Search for other papers by Guoquan Zhu in
Google Scholar
PubMed
Search for other papers by Yuying Deng in
Google Scholar
PubMed
Search for other papers by Liqin Pan in
Google Scholar
PubMed
Search for other papers by Wei Ouyang in
Google Scholar
PubMed
Search for other papers by Huijuan Feng in
Google Scholar
PubMed
Search for other papers by Juqing Wu in
Google Scholar
PubMed
Search for other papers by Pan Chen in
Google Scholar
PubMed
Search for other papers by Jing Wang in
Google Scholar
PubMed
Search for other papers by Yanying Chen in
Google Scholar
PubMed
Search for other papers by Jiaxin Luo in
Google Scholar
PubMed
well as those with various subtypes of PTC. In addition, the BRAF V600E mutation was associated with poorer recurrence-free probability in Kaplan–Meier survival analyses in various clinicopathologic categories. Thus, the author suggested that the
Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
Search for other papers by Wentao Zhou in
Google Scholar
PubMed
Search for other papers by Tiantao Kuang in
Google Scholar
PubMed
Search for other papers by Xu Han in
Google Scholar
PubMed
Search for other papers by Wenqi Chen in
Google Scholar
PubMed
Search for other papers by Xuefeng Xu in
Google Scholar
PubMed
Search for other papers by Wenhui Lou in
Google Scholar
PubMed
Search for other papers by Dansong Wang in
Google Scholar
PubMed
dynamic enhanced CT or MRI. The primary outcome of this research is relapse-free survival (RFS), which was determined by the interval between the day of operation and the date of relapse or last follow-up. Similarly, overall survival (OS) was defined as